Tuberculosis Therapy
Data on tuberculosis therapy detailed by researchers at Karolinska Institut
Published in TB and Outbreaks Week, December 26th, 2006
Research findings, "Structural and thermodynamic insights into the binding mode of five novel inhibitors of lumazine synthase from Mycobacterium tuberculosis," are discussed in a new report. According to recent research published in the FEBS Journal, "Recently published genomic investigations of the human pathogen Mycobacterium tuberculosis have revealed that genes coding the proteins involved in riboflavin biosynthesis are essential for the growth of the organism. Because the enzymes involved in cofactor biosynthesis pathways are not present in humans, they appear to be promising candidates for the development of therapeutic drugs."
"The substituted...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of TB and Outbreaks Week
More Articles from TB and Outbreaks Week
- Avian Influenza
Immunization against secondary infections may reduce impact of influenza outbreak - Thrombophlebitis
Reports from University of Limpopo add new data to research in thrombophlebitis - Tuberculosis
New tuberculosis data have been reported by scientists at New York University, Department of Microbiology - Tuberculosis
New tuberculosis research has been reported by scientists at University of New Mexico - Tuberculosis
New tuberculosis study findings have been reported from National Institute of Allergy and Infectious Disease - Tuberculosis
Study results from University of Illinois, College of Pharmacy update understanding of tuberculosis - More from this issue of TB and Outbreaks Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
